Evidence map›Paper›PMID 32191302›Full record

ArticleEndocrinology2020

Human Follicle-Stimulating Hormone ß Subunit Expression Depends on FOXL2 and SMAD4.

Luisina Ongaro, Gauthier Schang, Ziyue Zhou, T Rajendra Kumar, Mathias Treier, Chu-Xia Deng, Ulrich Boehm, Daniel J Bernard

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Luisina OngaroDepartment of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.
Gauthier SchangDepartment of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.
Ziyue ZhouDepartment of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.
T Rajendra KumarDepartment of Obstetrics and Gynecology, University of Colorado Denver-Anschutz Medical Campus, Aurora, CO, US.
Mathias TreierMax-Delbrück Center for Molecular Medicine (MDC), Genetics of Metabolic and Reproductive Disorders, Berlin, Germany.
Chu-Xia DengFaculty of Health Sciences, University of Macau, China.
Ulrich BoehmExperimental Pharmacology, Center for Molecular Signaling (PZMS), Saarland University School of Medicine, Homburg, Germany.
Daniel J BernardDepartment of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.
McGill University · CAMax Delbrück Center · DESaarland University · DEUniversity of Colorado Anschutz Medical Campus · USUniversity of Macau · MO

Funding

The Aging Pituitary/Gonadal AxisP01AG029531 · NIA · WICHITA STATE UNIVERSITY · PI CHITTIBABU GUDA · 2009 to 2026
$25.9M
Gonadal and extra-gonadal actions of FSH glycoforms in agingR56AG056046 · NIA · UNIVERSITY OF COLORADO DENVER · PI KUMAR, T. RAJENDRA · 2017 to 2017
$481k
Canadian Institute of Health Research MOP-133394Canadian Institute of Health Research PJT-162343CIHR CIHR-152308NIA NIH HHS P01 AG029531NIA NIH HHS R56 AG056046
6 · The paper itself

Abstract

Follicle-stimulating hormone (FSH), an essential regulator of mammalian fertility, is synthesized by pituitary gonadotrope cells in response to activins. In mice, activins signal via SMAD3, SMAD4, and FOXL2 to regulate transcription of the FSHβ subunit (Fshb) gene. Gonadotrope-specific deletion of Foxl2, alone or in combination with Smad4, renders mice FSH-deficient. Whether human FSHB expression is similarly regulated is not known. Here, we used a combination of transgenic and conditional knockout mouse strains to assess the roles of activins, FOXL2, and SMAD4 in regulation of the human FSHB gene. First, we cultured pituitaries from mice harboring a human FSHB transgene (hFSHB mice) and measured both murine Fshb and human FSHB messenger ribonucleic acid (mRNA) expression in response to exogenous activins or two antagonists of endogenous activin-like signaling (follistatin-288 and SB431542). Both murine Fshb and human FSHB expression were stimulated by activins and reduced by the inhibitors. Next, we analyzed human FSHB expression in hFSHB mice carrying floxed Foxl2 and Smad4 alleles. Cre-mediated ablation of FOXL2 and SMAD4 strongly reduced basal and activin-stimulated murine Fshb and human FSHB expression in cultured pituitaries. Finally, the hFSHB transgene was previously shown to rescue FSH production and fertility in Fshb knockout mice. However, gonadotrope-specific Foxl2/Smad4 knockout females carrying the hFSHB transgene have significantly reduced murine Fshb and human FSHB pituitary mRNA levels and are hypogonadal. Collectively, these data suggest that similar to Fshb regulation in mice, FOXL2 and SMAD4 play essential roles in human FSHB expression.

Indexed as

ActivinsAnimalsFemaleFollicle Stimulating Hormone, beta SubunitForkhead Box Protein L2Gene ExpressionHumansMaleMice, KnockoutMice, TransgenicPituitary GlandRNA, MessengerSmad4 ProteinTissue Culture TechniquesActivinsFollicle Stimulating Hormone, beta SubunitForkhead Box Protein L2RNA, MessengerSmad4 ProteinactivinFOXL2FSHgonadotropepituitarySMAD4transgene

Identifiers

PMID32191302
PMCPMC7182064
OpenAlexW3012428579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.